Irhythm Technologies Inc. | Mid-cap | Healthcare
$160.56
1.30%
| Irhythm Technologies Stock Comparison:
Irhythm Technologies vs Abbott LaboratoriesIrhythm Technologies vs Boston ScientificIrhythm Technologies vs PenumbraIrhythm Technologies vs Globus MedicalIrhythm Technologies vs MasimoIrhythm Technologies vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 158.7M
Gross Profit 109.2M 68.83%
Operating Income -32.6M -20.52%
Net Income -30.7M -19.35%
EPS (Diluted) $-0.97

Balance Sheet Metrics

Total Assets 926.1M
Total Liabilities 839.4M
Shareholders Equity 86.7M
Debt to Equity 9.69

Cash Flow Metrics

Operating Cash Flow -31.2M
Free Cash Flow -17.3M

Revenue & Profitability Trend

Irhythm Technologies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i591.8M492.7M410.9M322.8M265.2M
Cost of Goods Sold i184.3M160.9M129.3M109.3M70.3M
Gross Profit i407.5M331.8M281.6M213.6M194.9M
Gross Margin % i68.9%67.3%68.5%66.2%73.5%
Operating Expenses
Research & Development i103.8M60.2M46.6M38.7M41.3M
Selling, General & Administrative i418.6M385.6M322.2M274.8M197.2M
Other Operating Expenses i-----
Total Operating Expenses i522.4M445.9M368.8M313.5M238.6M
Operating Income i-114.9M-114.1M-87.2M-99.9M-43.7M
Operating Margin % i-19.4%-23.2%-21.2%-31.0%-16.5%
Non-Operating Items
Interest Income i21.9M6.2M2.0M118.0K-
Interest Expense i12.8M3.6M4.1M1.2M1.5M
Other Non-Operating Income-7.0M-11.1M-26.6M118.0K1.6M
Pre-tax Income i-112.7M-122.7M-115.9M-101.0M-43.6M
Income Tax i565.0K750.0K269.0K367.0K229.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-113.3M-123.4M-116.2M-101.4M-43.8M
Net Margin % i-19.1%-25.0%-28.3%-31.4%-16.5%
Key Metrics
EBITDA i-65.9M-85.8M-65.5M-83.2M-29.2M
EPS (Basic) i$-3.63$-4.04$-3.88$-3.46$-1.58
EPS (Diluted) i$-3.63$-4.04$-3.88$-3.46$-1.58
Basic Shares Outstanding i3119600030528000299160002933100027754404
Diluted Shares Outstanding i3119600030528000299160002933100027754404

Income Statement Trend

Irhythm Technologies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i419.6M36.2M78.8M127.6M88.6M
Short-term Investments i116.0M97.6M134.3M111.6M246.6M
Accounts Receivable i79.9M61.5M49.9M46.4M29.9M
Inventory i14.0M14.0M15.2M10.3M5.3M
Other Current Assets16.3M21.6M10.6M9.7M7.4M
Total Current Assets i645.8M230.8M288.8M305.5M377.8M
Non-Current Assets
Property, Plant & Equipment i57.3M55.3M65.6M87.8M89.4M
Goodwill i1.7M1.7M1.7M1.7M1.7M
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets50.2M48.0M22.3M16.1M14.1M
Total Non-Current Assets i285.6M202.3M159.4M157.4M133.9M
Total Assets i931.4M433.1M448.2M463.0M511.7M
Liabilities
Current Liabilities
Accounts Payable i7.2M5.5M7.5M10.5M4.4M
Short-term Debt i15.9M15.2M13.0M22.8M19.8M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i110.9M107.4M89.1M87.9M65.7M
Non-Current Liabilities
Long-term Debt i721.0M114.7M118.0M94.9M102.6M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities8.6M1.0M1.3M697.0K1.8M
Total Non-Current Liabilities i729.6M115.7M119.3M95.6M104.5M
Total Liabilities i840.5M223.0M208.4M183.5M170.1M
Equity
Common Stock i31.0K31.0K28.0K27.0K27.0K
Retained Earnings i-758.9M-645.6M-522.2M-406.0M-304.7M
Treasury Stock i25.0M----
Other Equity-----
Total Shareholders Equity i90.9M210.1M239.8M279.5M341.6M
Key Metrics
Total Debt i736.9M129.8M131.0M117.7M122.5M
Working Capital i534.9M123.4M199.7M217.7M312.2M

Balance Sheet Composition

Irhythm Technologies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-113.3M-123.4M-116.2M-101.4M-43.8M
Depreciation & Amortization i25.8M22.1M19.6M16.6M12.9M
Stock-Based Compensation i76.0M77.2M57.7M54.5M41.5M
Working Capital Changes i-97.0M-110.3M-79.1M-51.8M-54.5M
Operating Cash Flow i-72.9M-134.0M-117.7M-75.3M-37.9M
Investing Activities
Capital Expenditures i-33.9M-40.4M-29.8M-28.1M-13.6M
Acquisitions i-----
Investment Purchases i-175.2M-167.3M-188.6M-122.2M-277.5M
Investment Sales i101.2M206.5M166.0M255.5M158.7M
Investing Cash Flow i-108.0M-1.2M-52.4M105.3M-132.4M
Financing Activities
Share Repurchases i-25.0M----
Dividends Paid i-----
Debt Issuance i736.2M035.0M00
Debt Repayment i-116.4M0-21.4M-11.7M-1.9M
Financing Cash Flow i502.9M013.5M-37.5M194.1M
Free Cash Flow i-45.6M-90.5M-52.8M-65.8M-27.3M
Net Change in Cash i322.0M-135.2M-156.6M-7.6M23.8M

Cash Flow Trend

Irhythm Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -44.09
Forward P/E -86.14
Price to Book 49.09
Price to Sales 7.75
PEG Ratio -86.14

Profitability Ratios

Profit Margin -14.06%
Operating Margin -5.71%
Return on Equity -91.14%
Return on Assets -3.53%

Financial Health

Current Ratio 5.02
Debt to Equity 708.80
Beta 1.41

Per Share Data

EPS (TTM) $-2.92
Book Value per Share $3.23
Revenue per Share $20.83

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
irtc5.1B-44.0949.09-91.14%-14.06%708.80
Abbott Laboratories 233.7B16.834.6230.93%32.43%26.50
Boston Scientific 152.8B61.396.8111.55%13.55%53.09
Penumbra 9.4B63.627.2212.03%11.54%17.04
Globus Medical 7.9B43.771.848.62%13.58%2.83
Masimo 7.9B129.167.54-22.37%-21.32%61.58

Financial data is updated regularly. All figures are in the company's reporting currency.